Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05677035

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects

Conditions: Contraception

Sex: Female
Ages: 19 Years – 50 Years
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 20
Sponsor: Hyundai Pharm

Location: Korea, Republic of

Summary

A single-center, open-label, parallel-group, phase 1 study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of LINO-1713 in healthy Korean female subjects

Eligibility Criteria

Inclusion Criteria:Women with a Body Mass Index (BMI) between 18kg/m2 ~ 28kg/m2Exclusion Criteria:Clinically significant cardiovascular disease, respiratory disease

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05677035). StuddyBuddy aggregates publicly available trial information.